Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma
Cells · 19.04.2026 · 15 (8) · 722
DOI: 10.3390/cells15080722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 19.04.2026. Verfasst von Laura Gramantieri und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Liver Neoplasms, Carcinoma, Hepatocellular, Protein-Tyrosine Kinases. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, European Union - NextGenerationEU, Cassa di Risparmio in Bologna.
Abstract (Originalsprache)
Transarterial chemoembolization (TACE) is the standard treatment for patients with intermediate-stage hepatocellular carcinoma (HCC), yet nearly half of treated patients fail to achieve durable benefit, and reliable biomarkers enabling early therapeutic stratification are still lacking. Treatment response is typically assessed by imaging one month after TACE and at three-month intervals, potentially delaying timely access to alternative therapies in non-responding patients. Circulating microRNAs (miRNAs) represent promising biomarkers due to their stability in body fluids and ease of detection. Here, we evaluated circulating miR-22 as an early predictor of TACE non-responder status and as a mechanistically relevant therapeutic target. Circulating miR-22 levels were measured by microarray and quantitative RT–PCR in three independent cohorts of early-to-intermediate-stage HCC patients undergoing TACE. Circulating miR-22 increased significantly in non-responders as early as 48 h after treatment, and fold changes consistently predicted treatment failure across two independent validation cohorts. Mechanistically, we identified the G2/M checkpoint kinase WEE1 as a direct functional target of miR-22. Modulation of the miR-22/WEE1 axis affected cell-cycle progression, proliferation, apoptosis, and DNA damage response in HCC cell lines and xenograft models. Under hypoxia-mimicking conditions combined with doxorubicin exposure, pharmacological inhibition of WEE1 induced mitotic catastrophe in highly proliferative miR-22-silenced cells. Collectively, these findings identify early post-TACE elevation of circulating miR-22 as a biomarker of non-response and highlight the miR-22/WEE1 axis as a potential target for precision treatment strategies in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Department for Life Quality Studies, University of Bologna, 47921 Rimini, Italy.
- Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
- Department of Farmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
ORCID-Profile: Laura Gramantieri, Giuseppe Galvani, Elisa Monti, Giorgia Marisi, Irene Salamon, Manuela Ferracin, Gloria Ravegnini, Catia Giovannini, Fabio Piscaglia, Camelia A Coada, Giuseppe Francesco Foschi, Davide Trerè, Francesca Fornari
Förderung
- Italian Association for Cancer Research
- European Union - NextGenerationEU
- Cassa di Risparmio in Bologna
- AIRC
- Italian Ministry of University and Research
- Fondazione Cassa di Risparmio in Bologna
Zitieren
APA
Gramantieri, L., Vianello, C., Leoni, I., Galvani, G., Monti, E., Bella, M., Marisi, G., Salamon, I., Ferracin, M., Ravegnini, G., Giovannini, C., Stefanelli, C., Lazzari, M. L., Piscaglia, F., Coada, C. A., Bassi, C., Negrini, M., Casadei-Gardini, A., Foschi, G. F., …, & Fornari, F. (2026). Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma. Cells, 15(8), 722. https://doi.org/10.3390/cells15080722
Vancouver
Gramantieri L, Vianello C, Leoni I, Galvani G, Monti E, Bella M, et al. Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma. Cells. 2026;15(8):722. doi:10.3390/cells15080722
BibTeX
@article{Gramantieri2026,
author = {Gramantieri, Laura and Vianello, Clara and Leoni, Ilaria and Galvani, Giuseppe and Monti, Elisa and Bella, Marco and Marisi, Giorgia and Salamon, Irene and Ferracin, Manuela and Ravegnini, Gloria and Giovannini, Catia and Stefanelli, Claudio and Lazzari, Maria Laura and Piscaglia, Fabio and Coada, Camelia A and Bassi, Cristian and Negrini, Massimo and Casadei-Gardini, Andrea and Foschi, Giuseppe Francesco and Trerè, Davide and Fornari, Francesca},
title = {Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma},
journal = {Cells},
year = {2026},
volume = {15},
number = {8},
pages = {722},
doi = {10.3390/cells15080722}
}
EUVIMED